New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Gene scissors find target for testicular cancer therapy

Gene scissors find target for testicular cancer therapy

byUniversity of BonnCulture of testicular cancer cells under Cisplatin at day 28: While the cells on the left almost all dead, individual cells in the right culture treated with the gene scissor
World medicine December 10,2023
Gene scissors find target for testicular cancer therapy

Gene scissors find target for testicular cancer therapy

byUniversity of BonnCulture of testicular cancer cells under Cisplatin at day 28: While the cells on the left almost all dead, individual cells in the right culture treated with the gene scissor
World medicine December 10,2023
Genetic testing: Helping patients understand their risk for cancer, and ways to reduce that risk

Genetic testing: Helping patients understand their risk for cancer, and ways to reduce that risk

by Donna Fisher,Rush University Medical CenterHillary Knowles, DNP. Credit: Rush University Medical CenterSome 10% of cancers may be hereditary. And thanks to genetic testing, you can now determ
World medicine December 10,2023
Genetic testing: Helping patients understand their risk for cancer, and ways to reduce that risk

Genetic testing: Helping patients understand their risk for cancer, and ways to reduce that risk

by Donna Fisher,Rush University Medical CenterHillary Knowles, DNP. Credit: Rush University Medical CenterSome 10% of cancers may be hereditary. And thanks to genetic testing, you can now determ
World medicine December 10,2023
Gene engineered cell therapy developed to target brain metastatic melanomas

Gene engineered cell therapy developed to target brain metastatic melanomas

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainOverall survival for patients with melanoma that has spread to the brain is only four to six months. Immunotherapies, which ha
World medicine December 10,2023
Gene engineered cell therapy developed to target brain metastatic melanomas

Gene engineered cell therapy developed to target brain metastatic melanomas

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainOverall survival for patients with melanoma that has spread to the brain is only four to six months. Immunotherapies, which ha
World medicine December 10,2023
Gene expression signatures indicate loss of function by master regulators of the genome

Gene expression signatures indicate loss of function by master regulators of the genome

by Rob Levy,Broad Institute of MIT and HarvardCredit: Broad CommunicationsSecond only to the notorious TP53 gene, the genes for assemblages known as mSWI/SNF protein complexes are the most frequ
World medicine December 10,2023
Gene expression signatures indicate loss of function by master regulators of the genome

Gene expression signatures indicate loss of function by master regulators of the genome

by Rob Levy,Broad Institute of MIT and HarvardCredit: Broad CommunicationsSecond only to the notorious TP53 gene, the genes for assemblages known as mSWI/SNF protein complexes are the most frequ
World medicine December 10,2023
Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer

Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer

byLancetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Results from a randomised controlled trial involving 300
World medicine December 09,2023
Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer

Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer

byLancetMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Results from a randomised controlled trial involving 300
World medicine December 09,2023
Brake on immune activity identified, raising new possibilities for anticancer therapy

Brake on immune activity identified, raising new possibilities for anticancer therapy

byTemple UniversityCredit: CC0 Public DomainThe immune system is like a carefully regulated machine, complete with its own built-in "brakes" that prevent it from overreacting and causi
World medicine December 09,2023
Brake on immune activity identified, raising new possibilities for anticancer therapy

Brake on immune activity identified, raising new possibilities for anticancer therapy

byTemple UniversityCredit: CC0 Public DomainThe immune system is like a carefully regulated machine, complete with its own built-in "brakes" that prevent it from overreacting and causi
World medicine December 09,2023
Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation

Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation

byUniversity of Texas M. D. Anderson Cancer CenterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Although metast
World medicine December 09,2023
Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation

Immunotherapy effective in metastatic prostate cancers with specific markers of immune activation

byUniversity of Texas M. D. Anderson Cancer CenterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Although metast
World medicine December 09,2023
Mathematical model predicts patient outcomes to adaptive therapy

Mathematical model predicts patient outcomes to adaptive therapy

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Prostate c
World medicine December 09,2023
Mathematical model predicts patient outcomes to adaptive therapy

Mathematical model predicts patient outcomes to adaptive therapy

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Prostate c
World medicine December 09,2023
New artificial intelligence system can empower medical professionals in diagnosing skin diseases

New artificial intelligence system can empower medical professionals in diagnosing skin diseases

byElsevierHuman skin structure. Credit: WikipediaResearchers in Korea have developed a deep learning-based artificial intelligence (AI) algorithm that can accurately classify cutaneous skin diso
World medicine December 09,2023
New artificial intelligence system can empower medical professionals in diagnosing skin diseases

New artificial intelligence system can empower medical professionals in diagnosing skin diseases

byElsevierHuman skin structure. Credit: WikipediaResearchers in Korea have developed a deep learning-based artificial intelligence (AI) algorithm that can accurately classify cutaneous skin diso
World medicine December 09,2023
A smart bra for detecting early-stage breast cancer

A smart bra for detecting early-stage breast cancer

by Leila Ueberschlag,Ecole Polytechnique Federale de LausanneCredit: Ecole Polytechnique Federale de LausanneEPFL students teamed up with startup IcosaMed to develop the SmartBra—the first piece
World medicine December 09,2023
A smart bra for detecting early-stage breast cancer

A smart bra for detecting early-stage breast cancer

by Leila Ueberschlag,Ecole Polytechnique Federale de LausanneCredit: Ecole Polytechnique Federale de LausanneEPFL students teamed up with startup IcosaMed to develop the SmartBra—the first piece
World medicine December 09,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com